Effect of adding hydrochlorothiazide to usual treatment of patients with acute decompensated heart failure: a randomized clinical trial
Abstract Acute decompensated heart failure (ADHF) is the leading cause of hospitalization in patients aged 65 years or older, and most of them present with congestion. The use of hydrochlorothiazide (HCTZ) may increase the response to loop diuretics. To evaluate the effect of adding HCTZ to furosemi...
Guardado en:
Autores principales: | Diogo Silva Piardi, Maurício Butzke, Ana Carolina Martins Mazzuca, Bruna Sessim Gomes, Sofia Giusti Alves, Bruno Jaskulski Kotzian, Eduarda Chiesa Ghisleni, Vanessa Giaretta, Priscila Bellaver, Gabrielle Aguiar Varaschin, Arthur Pereira Garbin, Luís Beck-da-Silva |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f3a183176446485bb7e0fb0736a57c05 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Effect of adding hydrochlorothiazide to usual treatment of patients with acute decompensated heart failure: a randomized clinical trial
por: Diogo Silva Piardi, et al.
Publicado: (2021) -
STABILITY - INDICATING LC METHOD FOR THE SIMULTANEOUS DETERMINATION OF TELMISARTAN AND HYDROCHLOROTHIAZIDE IN DOSAGE FORM
por: PATIL,KIRAN R, et al.
Publicado: (2012) -
Management options in decompensated cirrhosis
por: Shah NL, et al.
Publicado: (2015) -
Direcciones cablegráficas mas usuales
Publicado: (2014) -
Role of Levosimendan in acute decompensated heart failure
por: V.K. Katyal, et al.
Publicado: (2021)